|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Employee Stock Option (right-to-buy) | $ 70.21 | 10/25/2024 | M | 19,585 | (8) | 02/17/2025 | Common Stock | 19,585 | $ 0 | 0 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Levy Susan Cohen 50 SOUTH LA SALLE ST CHICAGO, IL 60603 |
EVP and General Counsel | |||
| David A. Serna, Attorney-in-Fact for Susan C. Levy | 10/29/2024 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Includes 17,132 stock units payable automatically on a 1-for-1 basis in shares of the Corporation's common stock. |
| (2) | On June 13, 2024, the reporting person's 2022 grantor retained annuity trust ("GRAT") distributed 18,966 shares of the Corporation's common stock to the reporting person's existing brokerage account as a final annuity payment in accordance with the terms of the GRAT instrument. |
| (3) | On June 13, 2024, the reporting person's 2023 GRAT distributed 19,000 shares of the Corporation's common stock to the reporting person's existing brokerage account as an annuity payment in accordance with the terms of the GRAT instrument. |
| (4) | Reflects the August 12, 2024 transfer of 55,726 shares of the Corporation's common stock into a newly created 2024 GRAT. |
| (5) | Reflects a correction of 9,730 net shares previously reported as being (i) distributed from the reporting person's 2022 GRAT to the reporting person's existing irrevocable trust as an annuity payment on June 9, 2023 (34,500 shares); and (ii) transferred from the reporting person's existing irrevocable trust into a newly created 2023 GRAT on June 12, 2023 (44,230 shares). Each of the foregoing transactions actually occurred from the reporting person's existing brokerage account, not the existing irrevocable trust. |
| (6) | Price reflects the weighted average sales price from $102.25 to $102.40. Information regarding the number of shares sold at each separate price will be provided by the reporting person upon request. |
| (7) | The reporting person's spouse is trustee of this trust. |
| (8) | This option became exercisable in four equal annual installments beginning on February 17, 2016. |